<i>PIK3CA</i> Mutations Are Associated With Lower Rates of Pathologic Complete Response to Anti–Human Epidermal Growth Factor Receptor 2 (HER2) Therapy in Primary HER2-Overexpressing Breast Cancer
2014 · Journal of Clinical Oncology · 252 citations
https://doi.org/10.1200/jco.2014.55.7876